Home › ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development
 

Keywords :   


ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development

2013-01-09 18:00:00| drugdiscoveryonline News Articles

ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, recently announced the launch of its Dip and Read Anti-Human Fab-CH1 biosensor

Tags: read development human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11100 SMAX
15.11ANABoeing 747JA809518cm660g
15.1114
15.11
15.11PS3 CECH2500A
15.11
15.11T
15.11adidas
More »